39 related articles for article (PubMed ID: 17218236)
21. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
Gallinat A
J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
[TBL] [Abstract][Full Text] [Related]
22. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
Gallinat A
Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
[TBL] [Abstract][Full Text] [Related]
23. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
24. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
25. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
26. [Cryoablation of endometrium in the treatment of pathological metrorrhagia].
Zak H; Baranowski W
Pol Merkur Lekarski; 2005 Nov; 19(113):716-8. PubMed ID: 16498819
[TBL] [Abstract][Full Text] [Related]
27. Future developments in the medical treatment of abnormal uterine bleeding: what can we expect?
Simon JA
Menopause; 2011 Apr; 18(4):462-6. PubMed ID: 21701433
[TBL] [Abstract][Full Text] [Related]
28. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
Fulop T; Rákóczi I; Barna I
J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
[TBL] [Abstract][Full Text] [Related]
29. Second-generation endometrial ablation treatment: Novasure.
Bongers MY
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
[TBL] [Abstract][Full Text] [Related]
30. Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices.
Cooper J; Gimpelson RJ
J Reprod Med; 2004 Apr; 49(4):267-73. PubMed ID: 15134151
[TBL] [Abstract][Full Text] [Related]
31. The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding.
Munro MG; Dickersin K; Clark MA; Langenberg P; Scherer RW; Frick KD;
Menopause; 2011 Apr; 18(4):445-52. PubMed ID: 21701431
[TBL] [Abstract][Full Text] [Related]
32. [Endometrial thermocoagulation via balloon: technique, mechanism of action, and evaluation].
Brun JL; Geoffrion H; Harle T; Leng JJ
Gynecol Obstet Fertil; 2000 Apr; 28(4):303-8. PubMed ID: 10859892
[TBL] [Abstract][Full Text] [Related]
33. Ten-year literature review of global endometrial ablation with the NovaSure® device.
Gimpelson RJ
Int J Womens Health; 2014; 6():269-80. PubMed ID: 24648771
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
